Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: QVAR 40

Summary for Tradename: QVAR 40

Suppliers: see list3
patent expirations by year for
 QVAR 40

Pharmacology for Tradename: QVAR 40

Clinical Trials for: QVAR 40

Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)
Status: Completed Condition: Asthma

Childhood Asthma Research and Education (CARE) Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)
Status: Completed Condition: Asthma

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications
Status: Completed Condition: Asthma; Obesity

A Study Evaluating the Effect of Inhaled and Nasal Corticosteroids on Short Term Growth in Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Status: Recruiting Condition: Asthma; Allergic Rhinitis

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR
Status: Completed Condition: Seasonal Allergic Rhinitis; Hayfever

A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults
Status: Completed Condition: Pharmacokinetics

Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma
Status: Completed Condition: Asthma

Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI
Status: Completed Condition: Asthma

Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)
Status: Completed Condition: Allergic Rhinitis

Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis
Status: Not yet recruiting Condition: Idiopathic Pulmonary Fibrosis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911Sep 15, 2000RXYes5,605,674<disabled><disabled>
Teva Branded Pharm
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911Sep 15, 2000RXYes5,683,677<disabled>Y<disabled>
Teva Branded Pharm
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911Sep 15, 2000RXYes5,776,432<disabled>Y<disabled>
Teva Branded Pharm
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911Sep 15, 2000RXYes6,446,627<disabled>Y<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology